Our Services

This is our core service, covering technology transfer, process development, optimization, and cGMP manufacturing for clinical and commercial applications. All of our advanced therapy medicinal products (ATIMPs and ATMPs) are produced under strict cGMP conditions for administration to patients.

Learn more

All cell therapies begin with cells generously donated by individuals. These donations can serve different purposes depending on the type of therapy. Some are patient-specific (autologous cell therapies), where cells are taken from and used to treat the same individual. Others are designed to treat multiple patients with the same condition (allogeneic cell therapies), using cells from a single donor. There is also a middle ground, where cells are matched as closely as possible to a specific patient to minimize adverse immune reactions, often using HLA typing or haplotyping to ensure compatibility.

Learn more

For autologous cell therapies, cells must be collected from the patient, transported to a manufacturing facility (either at FamiCord or another location), processed or modified, and then returned to the hospital for re-administration to the patient. This process demands exceptional coordination, as speed is critical to ensure the cells remain viable. Additionally, the cells often need to be cryopreserved at -150°C for transit, a highly skilled and strictly regulated procedure.

Learn more